Parnax Lab Limited has scheduled a meeting of the Board of Directors to be held on Friday, August 14, 2026, at the company's registered office located at 114, Bldg. No. 8, Jogani Industrial Complex, Sion-Chunabhatti, Mumbai - 400 022, India.
The primary agenda for the board meeting includes:
- Consideration and approval of Standalone and Consolidated Un-audited IND-AS Compliant Financial Results along with Limited Review Report for the quarter (Q1) and year ended 30th June, 2026
- This is being conducted pursuant to Regulation 33 of the Listing Obligation and Disclosure Requirements, 2015
- Any other business with the permission of the Chair
The company will submit the approved financial results to the Bombay Stock Exchange after the conclusion of the board meeting.
In compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the company's "Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company", the trading window for dealing in the equity shares of the company has been closed for concerned persons effective from July 1, 2026. The trading window will reopen 48 hours after the declaration of the unaudited financial results.
The disclosure is signed by Preet Vijay Kukreja, Company Secretary & Compliance Officer (Membership No. ACS 56761), acting on behalf of Parnax Lab Limited.